| Literature DB >> 33941603 |
Vania Modesto-Lowe1, Agata K Harabasz2, Sophia A Walker3.
Abstract
The second-generation antipsychotic drug quetiapine (Seroquel) is increasingly being used off-label for treating insomnia in the general population, possibly to avoid standard medications with known addictive qualities and adverse side effects. However, evidence to support using it in this way is scant, and quetiapine is associated with weight gain and other metabolic effects. It must be used cautiously and with appropriate monitoring for adverse effects and abuse.Entities:
Year: 2021 PMID: 33941603 DOI: 10.3949/ccjm.88a.20031
Source DB: PubMed Journal: Cleve Clin J Med ISSN: 0891-1150 Impact factor: 2.321